BBIO Latest Headlines

BridgeBio Pharma: Buy Rating Reiterated as Acoramidis Data Strengthen Efficacy Profile and 12-Month Price Target Held at $120

at www.tipranks.com (Wed, 2-Sep 6:15 AM)

AM Markets Need to Know: Nasdaq rebounds in August, Anthropic expands AI capacity, and more

at seekingalpha.com (Tue, 1-Sep 6:25 AM)

Trump unveils new drug-pricing accords with CSL, Astellas, and other biotech drugmakers

at seekingalpha.com (Tue, 1-Sep 12:10 AM)

BridgeBio Pharma Expands Access to Rare Disease Therapies

at www.tipranks.com (Mon, 31-Aug 4:17 PM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioMarin Pharmaceutical (BMRN) and BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 31-Aug 11:00 AM)

Jefferies Remains a Buy on BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 31-Aug 10:15 AM)

Cantor Fitzgerald Remains a Buy on BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 31-Aug 9:35 AM)

Piper Sandler Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 31-Aug 7:36 AM)

Barclays Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 31-Aug 3:59 AM)